Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

S100A9 anticorps

Cet anticorps anti-S100A9 est un anticorps Souris Monoclonal détectant S100A9 dans WB, FACS, IHC (p), EIA et IHC (fro). Adapté pour Humain. Ce Primary Antibody a été cité dans 2+ publications.
N° du produit ABIN111888

Aperçu rapide pour S100A9 anticorps (ABIN111888)

Antigène

Voir toutes S100A9 Anticorps
S100A9 (S100 Calcium Binding Protein A9 (S100A9))

Reactivité

  • 132
  • 29
  • 23
  • 7
  • 3
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 106
  • 56
  • 1
  • 1
  • 1
Souris

Clonalité

  • 94
  • 70
  • 1
Monoclonal

Conjugué

  • 72
  • 26
  • 17
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp S100A9 est non-conjugé

Application

  • 81
  • 60
  • 50
  • 31
  • 30
  • 28
  • 16
  • 15
  • 13
  • 13
  • 9
  • 8
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone

S32-2
  • Specificité

    Monoclonal antibody S32.2 identifies the Ca2+ -binding 14 kDa subunit of the inflammatory L-1 protein complex, also called S100A9 or Calgranulin B. The antigen is MRP14, the epitope is suspected in the carboxyterminal portion of the peptide. The antibody is useful for the characterization of circulating granulocytes or inflammatory infiltrates of the myelo-monocytic lineage which express MRP14/S100A9 differently depending on the inflammatory status of the disease. Antigen Distribution Isolated Cells: The antigen is found in granulocytes, stimulated monocytes and macrophages. It is absent from all other blood cells. In cultured monocytes, maximum MRP14 expression is found after 3-4 days. Myeloid leukaemia cells have been found to be positive as well. Tissue Sections: MRP14/S100A9 is found in a distinct subpopulation of inflammatory perivascular infiltrates of the myelo-monocytic lineage. Macrophages synthesise MRP14 increasingly during the early stages of inflammation. A high MRP14 (and low MRP8) expression by macrophages was reported in granulomatous diseases such as tuberculosis and sarcoidis. In non-granulomatous chronic inflammatory diseases like chronic rheumatoid arthritis, MRP8 and MRP14 positive cells consist of different subpopulations. During early inflammation endothelial cells are also positive with MRP8/14 determined by antibody 27E10 (Cat.-No. BM4025).Antigen Distribution Does not react with Bovine and Swine spleen.

    Purification

    Affinity Chromatography.

    Immunogène

    Cultured human monocytes.

    Isotype

    IgG1
  • Indications d'application

    ELISA. Immunohistochemistry on Frozen Sections: 0.5 μg/mL (1/400). Immunohistochemistry on Paraffin Sections: 1 μg/mL (1/200), pre-treatment for antigenretrieval not required. Has been described to work in FACS and Dot blots.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Reconstitution

    Restore with 0.5 mL distilled water.

    Concentration

    0.2 mg/mL

    Buffer

    Stock solution conatins PBS, pH 7.2 with 10 mg/mL BSA, 0.05 % Luviskol as stabilizer and 0.01 % Thimerosal as a preservative.

    Agent conservateur

    Thimerosal (Merthiolate)

    Précaution d'utilisation

    This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    -20 °C

    Stockage commentaire

    Store the lyophilized antibody at -20 °C. Following reconstitution it is stable for two weeks at 2 - 8 °C. Frozen aliquots are stable for 6 months when stored at -20 °C.

    Date de péremption

    6 months
  • Mortezai, Harder, Schnabel, Moors, Gauly, Schlüter, Wagener, Buck: "Tandem affinity depletion: a combination of affinity fractionation and immunoaffinity depletion allows the detection of low-abundance components in the complex proteomes of body fluids." dans: Journal of proteome research, Vol. 9, Issue 12, pp. 6126-34, (2010) (PubMed).

    Rosenberger, Thorey, Werner, Boukamp: "A novel regulator of telomerase. S100A8 mediates differentiation-dependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT." dans: The Journal of biological chemistry, Vol. 282, Issue 9, pp. 6126-35, (2007) (PubMed).

  • Antigène

    S100A9 (S100 Calcium Binding Protein A9 (S100A9))

    Autre désignation

    S100A9 / Calgranulin-B / MRP14

    Sujet

    S100A9 is a member of the S100 family of proteins. S100A9, together with S100A8 forms a heterodimeric protein complex, Calprotectin, which is a major calcium- and zinc-binding protein in the cytosol of neutrophils, monocytes, and keratinocytes. Complexes of S100A8 and S100A9 are the physiologically relevant forms of these proteins. S100A9 may function in the inhibition of casein kinase and altered expression of this protein is associated with the disease cystic fibrosis. Its expression and potential cytokine-like function in inflammation and in cancer suggest that S100A8/A9 may play a key role in inflammation-associated cancer.Synonyms: CAGB, Calprotectin L1H subunit, Leukocyte L1 complex heavy chain, MRP-14, Migration inhibitory factor-related protein 14, S100 calcium-binding protein A9, S100-A9

    ID gène

    9606

    UniProt

    P06702

    Pathways

    Transition Metal Ion Homeostasis, Positive Regulation of Endopeptidase Activity, S100 Proteins
Vous êtes ici:
Chat with us!